Transforming Big Pharma

Transforming Big Pharma addresses critically how strategy works in the pharmaceutical industry. John Ansell assesses the wide range of alternative strategies big pharma has been attempting in order to make up the shortfall in revenues stemming from the long-standing failure to develop sufficient new products. He shows that there is sound evidence t

Transforming Big Pharma abordeaza in mod critic modul in care functioneaza strategia in industria farmaceutica. John Ansell evalueaza gama larga de strategii alternative pe care big pharma le-a incercat pentru a compensa deficitul de venituri care rezulta din esecul de lunga durata de a dezvolta suficiente produse noi.